While distribution in other nations started soon after approval with pricing deals signed ahead of time, New Delhi and Serum Institute have engaged in months of haggling behind closed doors and are yet to sign a formal supply agreement. That has left at least 70 million vaccine doses in limbo.from Industry-Economic Times
Read The Rest:economictimes...
